NEWEGG COMMERCE INC (NEGG)

VGG6483G1000 - Common Stock

0.831  +0.04 (+5.7%)

After market: 0.8315 +0 (+0.06%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NEGG. NEGG was compared to 126 industry peers in the Specialty Retail industry. NEGG has a bad profitability rating. Also its financial health evaluation is rather negative. NEGG does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

NEGG had negative earnings in the past year.
In the past year NEGG has reported a negative cash flow from operations.
In the past 5 years NEGG reported 4 times negative net income.
In the past 5 years NEGG reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -13.72%, NEGG is doing worse than 76.98% of the companies in the same industry.
Looking at the Return On Equity, with a value of -42.27%, NEGG is doing worse than 69.05% of the companies in the same industry.
Industry RankSector Rank
ROA -13.72%
ROE -42.27%
ROIC N/A
ROA(3y)-19.38%
ROA(5y)-81.98%
ROE(3y)-43.79%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

NEGG has a worse Gross Margin (12.59%) than 90.48% of its industry peers.
The Profit Margin and Operating Margin are not available for NEGG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

NEGG does not have a ROIC to compare to the WACC, probably because it is not profitable.
NEGG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NEGG has been increased compared to 5 years ago.
NEGG has a worse debt/assets ratio than last year.

2.2 Solvency

NEGG has an Altman-Z score of 4.12. This indicates that NEGG is financially healthy and has little risk of bankruptcy at the moment.
NEGG has a Altman-Z score of 4.12. This is amongst the best in the industry. NEGG outperforms 86.51% of its industry peers.
NEGG has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
NEGG has a Debt to Equity ratio of 0.06. This is in the better half of the industry: NEGG outperforms 72.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 4.12
ROIC/WACCN/A
WACC9.25%

2.3 Liquidity

NEGG has a Current Ratio of 1.25. This is a normal value and indicates that NEGG is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.25, NEGG is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
NEGG has a Quick Ratio of 1.25. This is a bad value and indicates that NEGG is not financially healthy enough and could expect problems in meeting its short term obligations.
NEGG has a Quick ratio (0.57) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.57

2

3. Growth

3.1 Past

NEGG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -287.50%.
NEGG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.60%.
Measured over the past years, NEGG shows a very strong growth in Revenue. The Revenue has been growing by 353.18% on average per year.
EPS 1Y (TTM)-287.5%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-92%
Revenue 1Y (TTM)-27.6%
Revenue growth 3Y1526.23%
Revenue growth 5Y353.18%
Revenue growth Q2Q-9.06%

3.2 Future

NEGG is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by 0.00% yearly.
The Revenue is expected to decrease by -3.72% on average over the next years.
EPS Next Y-10%
EPS Next 2Y0%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-9.52%
Revenue Next 2Y-3.72%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

0

4. Valuation

4.1 Price/Earnings Ratio

NEGG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NEGG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for NEGG!.
Industry RankSector Rank
Dividend Yield N/A

NEWEGG COMMERCE INC

NASDAQ:NEGG (4/26/2024, 7:06:10 PM)

After market: 0.8315 +0 (+0.06%)

0.831

+0.04 (+5.7%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap315.89M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.72%
ROE -42.27%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 12.59%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover4.11
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.25
Quick Ratio 0.57
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-287.5%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-10%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-27.6%
Revenue growth 3Y1526.23%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y